BTAIVSHAE• 28 Days (Normalized)
BTAI vs HAE (BioXcel Therapeutics Inc. vs Haemonetics Corporation)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
HAE Performance $104.68
+1.71%
Haemonetics Corporation
Normalized Baseline0.00%
Alpha Spread Margin HAE LEADS
-1.71 pts
HAE outperforming by 1.71 percentage points
BTAIHAE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI HAE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BTAI Price | BTAI Gain (%) | HAE Price | HAE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $- | $104.68 | +1.71% | - | |
| Oct 01, 2026 | $- | $104.37 | +1.41% | - | |
| Sep 30, 2026 | $- | $105.30 | +2.31% | - | |
| Sep 29, 2026 | $- | $105.80 | +2.80% | - | |
| Sep 28, 2026 | $- | $105.79 | +2.79% | - | |
| Sep 25, 2026 | $- | $105.30 | +2.31% | - | |
| Sep 24, 2026 | $0.04 | -52.23% | $- | - | |
| Sep 23, 2026 | $0.05 | -39.11% | $106.82 | +3.79% | -42.90% |
| Sep 22, 2026 | $0.04 | -39.65% | $108.52 | +5.44% | -45.09% |
| Sep 21, 2026 | $0.06 | -16.78% | $108.73 | +5.65% | -22.43% |
| Sep 18, 2026 | $0.06 | -21.52% | $108.40 | +5.32% | -26.84% |
| Sep 17, 2026 | $0.08 | +1.62% | $107.60 | +4.55% | -2.93% |
| Sep 16, 2026 | $0.07 | -9.47% | $106.24 | +3.23% | -12.70% |
| Sep 15, 2026 | $0.04 | -39.51% | $106.20 | +3.19% | -42.70% |
| Sep 14, 2026 | $0.05 | -38.97% | $106.31 | +3.29% | -42.26% |
Page 1 of 2